Masimo Corporation Intrinsic Value Calculator – Victory Capital Management Reduces Stake in Masimo Corporation
June 17, 2023
🌥️Trending News
Masimo Corporation ($NASDAQ:MASI) is a publicly-traded global medical technology company that designs, manufactures, and markets innovative non-invasive patient monitoring solutions. The company’s products are designed to improve patient outcomes and reduce the total cost of care. Masimo’s technology has enabled clinicians to provide high-quality patient care for over two decades. It has revolutionized patient monitoring with its unique Measure-through Motion and Low Perfusion™ pulse oximetry technology, pioneering the use of signal processing, motion compensation, and adaptive algorithms to monitor for hypoxemia, arrhythmia, and other biomarkers.
Stock Price
Victory Capital Management Inc. has recently reduced its stake in MASIMO CORPORATION, a medical technology company based in Irvine, California. On Wednesday, MASIMO CORPORATION stock opened at $157.9 and closed at $161.8, up by 3.7% from its prior closing price of 156.1. This is a sign of confidence in the company and its products, which are designed to improve patient safety, reduce costs, and simplify workflow in the healthcare environment. The stock increase reflects the belief that MASIMO CORPORATION will continue to succeed in the medical technology sector. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Masimo Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 2.3k | 118.2 | 4.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Masimo Corporation. More…
| Operations | Investing | Financing |
| 6.6 | -1.04k | 507.4 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Masimo Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 3.12k | 1.79k | 25.2 |
Key Ratios Snapshot
Some of the financial key ratios for Masimo Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 33.0% | -6.9% | 8.6% |
| FCF Margin | ROE | ROA |
| -2.0% | 9.3% | 4.0% |
Analysis – Masimo Corporation Intrinsic Value Calculator
At GoodWhale, we have conducted a thorough analysis of the wellbeing of MASIMO CORPORATION. Our proprietary Valuation Line has determined that the intrinsic value of MASIMO CORPORATION shares is around $368.1, yet the current market price is much lower at $161.8. This means that the stock is currently undervalued by 56.0%. We believe that this discrepancy presents a great opportunity for investors who are looking to buy into a quality company at a discounted rate. More…
Peers
In the medical device industry, there is intense competition between Masimo Corp and its rivals Elekta AB, Essilorluxottica, and Compumedics Ltd. While all four companies offer innovative products and services, each has its own unique strengths and weaknesses. As a result, the competition between them is fierce, and it is often difficult for one company to gain a significant advantage over the others.
– Elekta AB ($OTCPK:EKTAY)
Despite a challenging year for the company, Elekta’s market cap has grown to 2.09B as of 2022. This is due in part to the company’s strong return on equity, which stands at 11.86%. Elekta is a leading provider of radiation therapy solutions for the treatment of cancer. The company’s products are used in over 6,000 hospitals and clinics around the world, and its solutions are backed by a team of over 3,000 employees.
– Essilorluxottica ($LTS:0OMK)
EssilorLuxottica is a French-Italian multinational corporation that designs, manufactures, and markets ophthalmic lenses, instruments, and equipment. The company has a presence in over 130 countries and employs more than 140,000 people. The company was formed in 2018 through the merger of Essilor International and Luxottica.
– Compumedics Ltd ($ASX:CMP)
Computedics Ltd is a technology company that provides computing and analytics solutions. The company has a market cap of 42.52M as of 2022 and a Return on Equity of 1.53%. Computedics Ltd provides computing and analytics solutions to businesses and organizations worldwide. The company offers a range of services, including data storage, cloud computing, data analysis, and security. Computedics Ltd is headquartered in Sydney, Australia.
Summary
Masimo Corporation is an innovative medical device company that designs, manufactures, and markets various patient monitoring and connectivity solutions. Investing in Masimo stock can be a viable option for investors looking to capitalize on the company’s successful track record of delivering reliable and cutting-edge medical solutions. Analysts have found that Masimo’s stock price has been relatively consistent over the past year. The company’s fundamentals have also been solid, with its cash flow from operating activities rising steadily over the same period.
Additionally, Victory Capital Management Inc. recently reduced its stake in the company, which could be seen as a positive indicator of market sentiment. Overall, investing in Masimo can be a wise choice for those looking to benefit from a reliable and well-performing company with a track record of success.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
